Irinotecan in Treating Patients With Refractory Solid Tumors and Liver Dysfunction
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Drugs used in chemotherapy us different ways to stop tumor cells from dividing so they stop
growing or die. Irinotecan may be effective in treating patients with refractory solid tumors
and liver dysfunction.